Michael Boeckh
Infectious Disease · Seattle, WANPI 1033310222
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,367 of the $59,120 with a category attached, or 64.9%. 9 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 45.3% of the total. Reporting peaked in 2024 at $37,919 and has fallen 96.0% since, to $1,500 in 2025. Among infectious disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $2273.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$27K
- Astrazeneca UK Limited$9K
- Gilead$8K
- GSK$6K
- ADMA Biomanufacturing LLC$5K
- Merck$2K
- plus $2K from 3 others
Across 168 payments — averaging $7680.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.2M
- Janssen Research & Development, LLC$39K
- Modernatx, Inc.$26K
- Ablynx NV$25K
- Gilead$3K
What the payments were for
- Consulting fees$38,36765%
- Travel & lodging$20,40435%
- Food & beverage$3491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $26,783 |
| Astrazeneca UK Limited | 2 | $9,486 |
| Gilead | 4 | $8,152 |
| GSK | 6 | $6,433 |
| ADMA Biomanufacturing LLC | 1 | $5,000 |
| Merck | 1 | $1,628 |
| Invivyd Inc | 1 | $1,500 |
| Modernatx, Inc. | 2 | $70 |
| AstraZeneca | 2 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIVTENCITY$26,737
- PEMGARDA$1,500
How this compares
$59,120 in reported general payments places this provider in the 95th percentile of 186 infectious disease providers in Washington.
Other infectious disease in Seattle
- Warren DingesSeattle$173K
- Paul DrainSeattle$149K
- Corey CasperSeattle$115K
- Anna WaldSeattle$103K
- Jim BoonyaratanakornkitSeattle$62K
- Jason GoldmanSeattle$58K
- Connie CelumSeattle$57K
- Hyang KimSeattle$51K
- Ferric FangSeattle$49K
- Heidi CraneSeattle$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.